IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET™ sensors with Masimo Measure-through Motion and Low Perfusion™ SET ® pulse oximetry have received FDA clearance with ...
Irvine, CA-based Masimo Corporation MASI recently announced the availability of the RD SedLine EEG sensor, which can be used with the company’s flagship SedLine Brain Function Monitoring technology.
The updated RD SET ® sensors’ SpO 2 accuracy specifications have improved significantly, from 3% to 1.5% A RMS1 (at 1 standard deviation), in conditions of motion and no motion, providing clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results